MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E202. A total of 19 filers reported holding MIRAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $878,000 | – | 53,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 550,000 | $9,048,000 | 0.78% |
| Fairmount Funds Management LLC | 35,092 | $554,000 | 0.20% |
| Soleus Capital Management, L.P. | 81,185 | $1,335,000 | 0.18% |
| RA Capital Management | 451,932 | $7,434,000 | 0.10% |
| Cormorant Asset Management, LP | 93,126 | $1,532,000 | 0.04% |
| Point72 Asset Management, L.P. | 426,162 | $7,010,000 | 0.03% |
| BVF INC/IL | 9,747 | $160,000 | 0.01% |
| Banque Cantonale Vaudoise | 3,333 | $55,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,392 | $23,000 | 0.00% |
| Renaissance Technologies | 53,402 | $878,000 | 0.00% |